Scientists test drug safety in people with liver issues
NCT ID NCT04546789
Summary
This small, completed study aimed to understand how liver problems affect how the body processes a drug called evobrutinib. It involved 24 people, some with healthy livers and some with mild or moderate liver impairment. Each participant received a single dose so researchers could measure the drug's levels and safety in their blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CRS Clinical Research Services Kiel GmbH
Kiel, Germany
Conditions
Explore the condition pages connected to this study.